02/19/2019
The expansion is expected to add 200 jobs in North Carolina, helping the drugmaker manufacture meds for rare genetic diseases
02/19/2019
The court's decision to reject Indivior's attempt to block copycats of its opioid addiction med is a win for generic drug maker Dr. Reddy's Laboratories
02/19/2019
The head of a small biotech firm had sharp words for the Pentagon over its lack of financial support for research into an experimental PTSD drug.
02/19/2019
A combination of treatments from Merck and Pfizer has shown to extend the life of patients with advanced kidney cancer.
02/18/2019
The U.S. FDA has announced new, efficient guidelines for the use of a novel pathway that provides incentives for developing generic versions of drugs that currently face little or no competition.
02/18/2019
Bayer has exercised its option, under a change-in-control clause in the collaboration agreement with Loxo Oncology, to obtain the exclusive licensing rights for the global development and commercialization of two cancer drugs.
02/15/2019
Generic drugmaker Glenmark Pharmaceuticals plans to spin off its innovation business into a new company in the U.S. which will offer branded drugs.
02/14/2019
During the racketeering trial for Insys Therapeutics founder, federal prosecutors shared a five-minute in-house rap video that they say was designed to motivate employees to push sales of a highly addictive fentanyl spray.
02/13/2019
McKesson Corp is back in the spotlight for opioid-related violations — this time involving rules under the 2013 Drug Supply Chain Security Act.
02/13/2019
An experimental nasal spray developed by Johnson & Johnson to treat depression could be headed for FDA approval.
